JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A4100 Droxinostat
2 Citation

Summary: Selective HDAC inhibitor
A4101 Tubastatin A
6 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥10.75 mg/mL
A4102 CI994 (Tacedinaline)
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥50 mg/mL
A4103 LAQ824 (NVP-LAQ824,Dacinostat)
1 Citation

Summary: HDAC inhibitor,potent and novel

insoluble in H2O; insoluble in EtOH; ≥17.45 mg/mL
A4104 AR-42 (OSU-HDAC42)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,novel and potent

insoluble in EtOH; insoluble in H2O; ≥15.62 mg/mL
A4105 M344
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,potent and cell-permeable
A4038 Alogliptin (SYR-322)
1 Citation

Target: DPP-4

Summary: DPP-4 inhibitor,potent and highly selective
A8205 Atazanavir
1 Citation

Summary: HIV protease inhibitor,highly potent

≥28.6 mg/mL
A4040 Atazanavir sulfate (BMS-232632-05)

Summary: Protease inhibitor

≥28.7 mg/mL
A8203 Ritonavir

Summary: HIV protease inhibitor

≥26 mg/mL